SNGX - SOLIGENIX, INC.
1.19
0.040 3.361%
Share volume: 93,305
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.15
0.04
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-08-2024 | 03-21-2025 | 05-09-2025 | 08-14-2025 | 11-07-2025 | |
| Assets | ||||||||
| Total Assets | 8.058 M | 9.865 M | 10.477 M | 8.966 M | 7.746 M | 5.761 M | 11.294 M | |
| Current Assets | 7.818 M | 9.663 M | 10.307 M | 8.829 M | 7.641 M | 5.320 M | 10.881 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 249.710 K | 5.861 K | 126.385 K | 103.847 K | 43.836 K | 31.682 K | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 25.253 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 7.092 M | 9.413 M | 9.840 M | 7.820 M | 7.297 M | 5.098 M | 10.525 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 10.339 K | 8.751 K | 7.162 K | 6.113 K | 5.505 K | 8.114 K | 7.812 K | |
| Other Assets | 229.659 K | 193.456 K | 162.925 K | 131.740 K | 99.873 K | 432.081 K | 405.192 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 8.058 M | 9.865 M | 10.477 M | 8.966 M | 7.746 M | 5.761 M | 11.294 M | |
| Total liabilities | 7.290 M | 6.400 M | 4.542 M | 4.848 M | 4.134 M | 3.932 M | 3.696 M | |
| Total current liabilities | 7.211 M | 6.355 M | 4.530 M | 4.848 M | 0.000 | 3.629 M | 3.422 M | |
| Accounts Payable | 1.437 M | 1.698 M | 891.227 K | 667.896 K | 599.688 K | 649.955 K | 1.207 M | |
| Other liabilities | 79.125 K | 45.691 K | 11.544 K | 0.000 | 0.000 | 302.589 K | 273.920 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 79.125 K | 45.691 K | 11.544 K | 0.000 | 0.000 | 302.589 K | 273.920 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 768.372 K | 3.465 M | 5.935 M | 4.118 M | 3.612 M | 1.829 M | 7.598 M | |
| Common stock | 228.364 M | 232.701 M | 236.881 M | 238.043 M | 240.774 M | 241.407 M | 249.707 M | |
| Retained earnings | -227.620 M | -229.264 M | -230.983 M | -233.971 M | -237.208 M | -239.624 M | -242.155 M |